欧州連合 - アイスランド語 - EMA (European Medicines Agency)

recordati rare diseases - Íbúprófen - slagæðarásar, einkaleyfi - hjarta meðferð - meðferð á blóðfrumumyndandi einkaleyfalyfjum í nýburum yngri en 34 vikna meðgöngutíma.

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatíð - osteoporosis; osteoporosis, postmenopausal - kalsíumsterastasis - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 300 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 150 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter holding b.v.* - paracetamolum inn - innrennslislyf, lausn - 10 mg/ml

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 50 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 200 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - quetiapinum fúmarat - forðatafla - 400 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

fresenius kabi ab - histidinum inn; phenylalaninum inn; leucinum inn; tyrosinum inn; serinum inn; lysinum inn; cysteinum inn; glycinum inn; prolinum inn; tryptophanum inn; methioninum inn; threoninum inn; isoleucinum inn; taurinum inn; acidum glutamicum inn; valinum inn; argininum inn; acidum asparticum inn; alaninum inn - innrennslislyf, lausn

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a - merkaptamín bítartrat - cystinosis - Önnur meltingarvegi og efnaskipti vörur, - procysbi er ætlað til meðferðar á sannaðri nýrnasjúkdómssýkingu. cysteamín dregur úr uppsöfnun cystíns í sumum frumum (e. hvítfrumum, vöðvum og lifrarfrumum) hjá sjúklingum með nýrnasjúkdóm í blöðruhálskirtli og þegar meðferð er hafin í byrjun, seinkar það þróun nýrnabilunar.